Related references
Note: Only part of the references are listed.The systemic delivery of siRNAs by a cell penetrating peptide, low molecular weight protamine
Young-Suk Choi et al.
BIOMATERIALS (2010)
Staying on message: design principles for controlling nonspecific responses to siRNA
Shirley Samuel-Abraham et al.
FEBS JOURNAL (2010)
Designing highly active siRNAs for therapeutic applications
S. Patrick Walton et al.
FEBS JOURNAL (2010)
Tat-BMPs-PAMAM Conjugates Enhance Therapeutic Effect of Small Interference RNA on U251 Glioma Cells In Vitro and In Vivo
Lei Han et al.
HUMAN GENE THERAPY (2010)
RNA interference in vitro and in vivo using an arginine peptide/siRNA complex system
Sung Wook Kim et al.
JOURNAL OF CONTROLLED RELEASE (2010)
siRNA delivery systems for cancer treatment
Yu-Kyoung Oh et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Acid-Responsive Linear Polyethylenimine for Efficient, Specific, and Biocompatible siRNA Delivery
Min Suk Shim et al.
BIOCONJUGATE CHEMISTRY (2009)
siRNA Conjugate Delivery Systems
Ji Hoon Jeong et al.
BIOCONJUGATE CHEMISTRY (2009)
A pH-sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivo
Hiroto Hatakeyama et al.
JOURNAL OF CONTROLLED RELEASE (2009)
In vivo siRNA delivery with dendritic poly(L-lysine) for the treatment of hypercholesterolemia
Kazuto Watanabe et al.
MOLECULAR BIOSYSTEMS (2009)
Biological Barriers to Therapy with Antisense and siRNA Oligonucleotides
R. Juliano et al.
MOLECULAR PHARMACEUTICS (2009)
Chitosan/siRNA Nanoparticle-mediated TNF-alpha Knockdown in Peritoneal Macrophages for Anti-inflammatory Treatment in a Murine Arthritis Model
Kenneth A. Howard et al.
MOLECULAR THERAPY (2009)
The promises and pitfalls of RNA-interference-based therapeutics
Daniela Castanotto et al.
NATURE (2009)
Knocking down barriers: advances in siRNA delivery
Kathryn A. Whitehead et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Targeting cyclin B1 through peptide-based delivery of siRNA prevents tumour growth
Laurence Crombez et al.
NUCLEIC ACIDS RESEARCH (2009)
Direct CNS Delivery of siRNA Mediates Robust Silencing in Oligodendrocytes
William Querbes et al.
OLIGONUCLEOTIDES (2009)
Virion-mimicking nanocapsules from pH-controlled hierarchical self-assembly for gene delivery
Peisheng Xu et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2008)
Cellular siRNA delivery mediated by a cell-permeant RNA-Binding protein and photoinduced RNA interference
Tamaki Endoh et al.
BIOCONJUGATE CHEMISTRY (2008)
Acetal linked oligoethylenimines for use as pH-sensitive gene carriers
Veronika Knorr et al.
BIOCONJUGATE CHEMISTRY (2008)
Application of an HIV gp41-derived peptide for enhanced intracellular trafficking of synthetic gene and siRNA delivery vehicles
Ester J. Kwon et al.
BIOCONJUGATE CHEMISTRY (2008)
Silencing HIV-1 in vivo
Frank Kirchhoff
CELL (2008)
Efficient gene silencing in metastatic tumor by siRNA formulated in surface-modified nanoparticles
Shyh-Dar Li et al.
JOURNAL OF CONTROLLED RELEASE (2008)
Mechanistic investigation of poly(ethylene imine)-based siRNA delivery: Disulfide bonds boost intracellular release of the cargo
Miriam Breunig et al.
JOURNAL OF CONTROLLED RELEASE (2008)
Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver
Michael J. Gray et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Novel dual inhibitory function aptamer-siRNA delivery system for HIV-1 therapy
Jiehua Zhou et al.
MOLECULAR THERAPY (2008)
Systemic leukocyte-directed siRNA delivery revealing cyclin D1 as an anti-inflammatory target
Dan Peer et al.
SCIENCE (2008)
Utility of Epstein-Barr virus-encoded small RNA promoters for driving the expression of fusion transcripts harboring short hairpin RNAs
Ey-W Choy et al.
GENE THERAPY (2008)
Therapeutic application of RNAi: is mRNA targeting finally ready for prime time?
Dirk Grimm et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits
M. DiFiglia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Mechanisms and optimization of in vivo delivery of lipophilic siRNAs
Christian Wolfrum et al.
NATURE BIOTECHNOLOGY (2007)
Transvascular delivery of small interfering RNA to the central nervous system
Priti Kumar et al.
NATURE (2007)
Utilizing RNA interference to enhance cancer drug discovery
Elizabeth Iorns et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Interfering with disease: a progress report on siRNA-based therapeutics
Antonin de Fougerolles et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Materializing the potential of small interfering RNA via a tumor-targeting nanodelivery system
Kathleen F. Pirollo et al.
CANCER RESEARCH (2007)
Toxicogenomics of non-viral drug delivery systems for RNAi: Potential impact on siRNA-mediated gene silencing activity and specificity
Saghir Akhtar et al.
ADVANCED DRUG DELIVERY REVIEWS (2007)
Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides
Bryan R. Meade et al.
ADVANCED DRUG DELIVERY REVIEWS (2007)
Fusogenic peptides enhance endosomal escape improving siRNA-induced silencing of oncogenes
Sabrina Oliveira et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2007)
Use of herpes simplex virus type 1-based amplicon vector for delivery of small interfering RNA
S. Sabbioni et al.
GENE THERAPY (2007)
RNAi therapeutics: a potential new class of pharmaceutical drugs
David Bumcrot et al.
NATURE CHEMICAL BIOLOGY (2006)
Construction of folate-conjugated pRNA of bacteriophage phi29 DNA packaging motor for delivery of chimeric siRNA to nasopharyngeal carcinoma cells (vol 13, pg 814, 2006)
S. Guo et al.
GENE THERAPY (2006)
Intravenous delivery of anti-RhoA small interfering RNA loaded in nanoparticles of chitosan in mice:: Safety and efficacy in xenografted aggressive breast cancer
J. -Y. Pille et al.
HUMAN GENE THERAPY (2006)
RNA interference in vitro and in vivo using a chitosan/siRNA nanoparticle system
Kenneth A. Howard et al.
MOLECULAR THERAPY (2006)
Cholesteryl oligoarginine delivering vascular endothelial growth factor siRNA effectively inhibits tumor growth in colon adenocarcinoma
Won Jong Kim et al.
MOLECULAR THERAPY (2006)
Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy
Jyotsnabaran Halder et al.
CLINICAL CANCER RESEARCH (2006)
Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras
James O. McNamara et al.
NATURE BIOTECHNOLOGY (2006)
Interfering antiviral immunity: application, subversion, hope?
N. Manjunath et al.
TRENDS IN IMMUNOLOGY (2006)
RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts
Marius Grzelinski et al.
HUMAN GENE THERAPY (2006)
Off-target effects by siRNA can induce toxic phenotype
Yuriy Fedorov et al.
RNA (2006)
RNAi-mediated gene silencing in non-human primates
TS Zimmermann et al.
NATURE (2006)
Adenovirus-mediated transfer of siRNA against PTTG1 inhibits liver cancer cell growth in vitro and in vivo
CR Jung et al.
HEPATOLOGY (2006)
Stable RNA interference:: comparison of U6 and H1 promoters in endothelial cells and in mouse brain
PI Mäkinen et al.
JOURNAL OF GENE MEDICINE (2006)
3′ UTR seed matches, but not overall identity, are associated with RNAi off-targets
A Birmingham et al.
NATURE METHODS (2006)
The silent treatment: siRNAs as small molecule drugs
DM Dykxhoorn et al.
GENE THERAPY (2006)
Comparative evaluation of target-specific GFP gene silencing efficiencies for antisense ODN, synthetic siRNA, and siRNA plasmid complexed with PEI-PEG-FOL conjugate
SH Kim et al.
BIOCONJUGATE CHEMISTRY (2006)
Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo
C Mamot et al.
CANCER RESEARCH (2005)
Intracellular trafficking of nonviral vectors
LK Medina-Kauwe et al.
GENE THERAPY (2005)
Low and high molecular weight poly(L-lysine)s/poly(L-lysine) - DNA complexes initiate mitochondrial-mediated apoptosis differently
P Symonds et al.
FEBS LETTERS (2005)
Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids
J Heyes et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs
DV Morrissey et al.
NATURE BIOTECHNOLOGY (2005)
Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery
CN Landen et al.
CANCER RESEARCH (2005)
Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors
EW Song et al.
NATURE BIOTECHNOLOGY (2005)
Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication
DV Morrissey et al.
HEPATOLOGY (2005)
A two-stage poly(ethylenimine)-mediated cytotoxicity: Implications for gene transfer/therapy
SM Moghimi et al.
MOLECULAR THERAPY (2005)
Full deacylation of polyethylenimine dramatically boosts its gene delivery efficiency and specificity to mouse lung
M Thomas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The NH2 terminus of influenza virus hemagglutinin-2 subunit peptides enhances the antitumor potency of polyarginine-mediated p53 protein transduction
H Michiue et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo
B Urban-Klein et al.
GENE THERAPY (2005)
Modulation of angiogenesis with siRNA inhibitors for novel therapeutics
PY Lu et al.
TRENDS IN MOLECULAR MEDICINE (2005)
Novel cationic cardiolipin analogue-based liposome for efficient DNA and small interfering RNA delivery in vitro and in vivo
PY Chien et al.
CANCER GENE THERAPY (2005)
Lactosylated poly(ethylene glycol)-siRNA conjugate through acid-labile ß-thiopropionate linkage to construct pH-sensitive polyion complex micelles achieving enhanced gene silencing in hepatoma cells
M Oishi et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
Lipid-mediated siRNA delivery down-regulates exogenous gene expression in the mouse brain at picomolar levels
Z Hassani et al.
JOURNAL OF GENE MEDICINE (2005)
Gene knockdown with intrathecal siRNA of NMDA receptor NR2B subunit reduces formalin-induced nociception in the rat
PH Tan et al.
GENE THERAPY (2005)
Inhibition of respiratory viruses by nasally administered siRNA
V Bitko et al.
NATURE MEDICINE (2005)
Cell-penetrating peptide conjugates of peptide nucleic acids (PNA) as inhibitors of HIV-1 Tat-dependent trans-activation in cells
JJ Turner et al.
NUCLEIC ACIDS RESEARCH (2005)
In vivo activity of nuclease-resistant siRNAs
JM Layzer et al.
RNA (2004)
Algorithm for selection of functional siRNA sequences
M Amarzguioui et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Small interfering RNA targeting heme oxygenase-1 enhances ischemia-reperfusion-induced lung apoptosis
XC Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis
JS Wadia et al.
NATURE MEDICINE (2004)
siRNA relieves chronic neuropathic pain
G Dorn et al.
NUCLEIC ACIDS RESEARCH (2004)
Therapeutic potential of retroviral RNAi vectors
E Devroe et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2004)
Unlocking the potential of the human genome with RNA interference
GJ Hannon et al.
NATURE (2004)
Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes - Therapeutic strategy for herpetic stromal keratitis
B Kim et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Antitumor activity of small interfering RNA/cationic liposome complex in mouse models of cancer
J Yano et al.
CLINICAL CANCER RESEARCH (2004)
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
J Soutschek et al.
NATURE (2004)
Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle
RM Schiffelers et al.
NUCLEIC ACIDS RESEARCH (2004)
Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo
Y Minakuchi et al.
NUCLEIC ACIDS RESEARCH (2004)
RNA interference using boranophosphate siRNAs: structure-activity relationships
AHS Hall et al.
NUCLEIC ACIDS RESEARCH (2004)
Steroid and lipid conjugates of siRNAs to enhance cellular uptake and gene silencing in liver cells
C Lorenz et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics
Y Takei et al.
CANCER RESEARCH (2004)
The design and exogenous delivery of siRNA for post-transcriptional gene silencing
IR Gilmore et al.
JOURNAL OF DRUG TARGETING (2004)
Liposomes modified with cyclic RGD peptide for tumor targeting
PK Dubey et al.
JOURNAL OF DRUG TARGETING (2004)
Cationic liposome-mediated delivery of siRNAs in adult mice
M Sioud et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Drug delivery and transport to solid tumors
SH Jang et al.
PHARMACEUTICAL RESEARCH (2003)
siRNA function in RNAi: A chemical modification analysis
YL Chiu et al.
RNA (2003)
Acid-triggered release via dePEGylation of DOPE liposomes containing acid-labile vinyl ether PEG-lipids
J Shin et al.
JOURNAL OF CONTROLLED RELEASE (2003)
RNA interference in mammalian cells by chemically-modified RNA
DA Braasch et al.
BIOCHEMISTRY (2003)
Expression profiling reveals off-target gene regulation by RNAi
AL Jackson et al.
NATURE BIOTECHNOLOGY (2003)
Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells
F Czauderna et al.
NUCLEIC ACIDS RESEARCH (2003)
Pollycation gene delivery systems: escape from endosomes to cytosol
YW Cho et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2003)
Gene silencing by systemic delivery of synthetic siRNAs in adult mice
DR Sorensen et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing
J Harborth et al.
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT (2003)
Gene silencing by adenovirus-delivered siRNA
CX Shen et al.
FEBS LETTERS (2003)
Gene silencing mediated by small interfering RNAs in mammalian cells
M Scherr et al.
CURRENT MEDICINAL CHEMISTRY (2003)
Cell-penetrating peptides - A reevaluation of the mechanism of cellular uptake
JP Richard et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Full-length proteins attached to the HIV tat protein transduction domain are neither transduced between cells, nor exhibit enhanced immunogenicity
JA Leifert et al.
GENE THERAPY (2002)
Stable suppression of tumorigenicity by virus-mediated RNA interference
TR Brummelkamp et al.
CANCER CELL (2002)
RNA interference in human cells is restricted to the cytoplasm
Y Zeng et al.
RNA (2002)
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
L Alexopoulou et al.
NATURE (2001)
TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors
VP Torchilin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
SM Elbashir et al.
NATURE (2001)
Arginine-rich peptides - An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery
S Futaki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
